Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and Pharmacokinetic/
Pharmacodynamic (PK/PD) profile of three doses of HM10560A on an every week (EW) regime and
one dose on every other week (EOW) regime administered for a period of 24 weeks initial
study.